Skip to main content

letter

. 1990 Sep 29;301(6753):667. doi: 10.1136/bmj.301.6753.667-a

Effect of erythropoietin in patients with myeloma.

S Rogers, N H Russell, A G Morgan

PMCID: PMC1663880 PMID: 2224226

667

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Dessypris E., Graber S. E., Krantz S. B., Stone W. J. Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood. 1988 Dec;72(6):2060–2062. [PubMed] [Google Scholar]
Geissler K., Stockenhuber F., Kabrna E., Hinterberger W., Balcke P., Lechner K. Recombinant human erythropoietin and hematopoietic progenitor cells in vivo. Blood. 1989 Jun;73(8):2229–2229. [PubMed] [Google Scholar]
Ludwig H., Fritz E., Kotzmann H., Höcker P., Gisslinger H., Barnas U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med. 1990 Jun 14;322(24):1693–1699. doi: 10.1056/NEJM199006143222402. [DOI] [PubMed] [Google Scholar]
Taylor J., Mactier R. A., Stewart W. K., Henderson I. S. Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis. BMJ. 1990 Sep 8;301(6750):476–477. doi: 10.1136/bmj.301.6750.476. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES